全文获取类型
收费全文 | 9432篇 |
免费 | 692篇 |
国内免费 | 281篇 |
专业分类
电工技术 | 414篇 |
技术理论 | 1篇 |
综合类 | 372篇 |
化学工业 | 1664篇 |
金属工艺 | 437篇 |
机械仪表 | 667篇 |
建筑科学 | 775篇 |
矿业工程 | 251篇 |
能源动力 | 276篇 |
轻工业 | 668篇 |
水利工程 | 121篇 |
石油天然气 | 559篇 |
武器工业 | 60篇 |
无线电 | 1161篇 |
一般工业技术 | 1406篇 |
冶金工业 | 450篇 |
原子能技术 | 117篇 |
自动化技术 | 1006篇 |
出版年
2024年 | 185篇 |
2023年 | 211篇 |
2022年 | 292篇 |
2021年 | 392篇 |
2020年 | 350篇 |
2019年 | 309篇 |
2018年 | 288篇 |
2017年 | 358篇 |
2016年 | 332篇 |
2015年 | 340篇 |
2014年 | 490篇 |
2013年 | 553篇 |
2012年 | 565篇 |
2011年 | 686篇 |
2010年 | 539篇 |
2009年 | 524篇 |
2008年 | 511篇 |
2007年 | 431篇 |
2006年 | 419篇 |
2005年 | 366篇 |
2004年 | 263篇 |
2003年 | 233篇 |
2002年 | 188篇 |
2001年 | 182篇 |
2000年 | 163篇 |
1999年 | 259篇 |
1998年 | 186篇 |
1997年 | 176篇 |
1996年 | 126篇 |
1995年 | 99篇 |
1994年 | 87篇 |
1993年 | 60篇 |
1992年 | 40篇 |
1991年 | 43篇 |
1990年 | 28篇 |
1989年 | 26篇 |
1988年 | 19篇 |
1987年 | 21篇 |
1986年 | 12篇 |
1985年 | 7篇 |
1984年 | 8篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1977年 | 2篇 |
1976年 | 5篇 |
1975年 | 2篇 |
1972年 | 2篇 |
1968年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
退火炉自动控制系统设计 总被引:3,自引:0,他引:3
山东烟台钢管总厂冷拔分厂退火炉自动控制系统的设计以微机、智能仪表、变频调速器为主,具有控制精度高、降低消耗、操作维修方便、提高劳动生产率等特点。 相似文献
22.
Manasa Sagaram Ranganathan Parthasarathy Sally L. Condon Charles F. Closson Maiying Kong Melanie L. Schwandt Loretta L. Jophlin Wenke Feng Ashutosh J. Barve Vatsalya Vatsalya 《International journal of molecular sciences》2022,23(10)
(1) Background: Fibrosis in early-stage alcohol-associated liver disease (ALD) is commonly under-diagnosed in routine clinical practice. This study characterized the liver-injury and cell death response in alcohol use disorder (AUD) patients with ALD who also exhibited fibrosis and assessed the efficacy of standard of care (SOC) treatment in the improvement in liver injury. (2) Methods: Forty-eight heavy-drinking AUD patients aged 21–65 yrs. without clinical manifestations of liver injury were grouped by Fibrosis-4 (FIB-4) score, as negative (Gr.1 < 1.45, n = 21) or positive (Gr.2 ≥ 1.45, n = 27). Patients received 2-weeks (2 w) inpatient SOC. Data on demographics, drinking patterns, liver-injury, immune markers, and liver cell death (K18s) markers were analyzed at baseline (BL) and after 2 w SOC. (3) Results: Lifetime drinking (LTDH, yrs.) and acute heavy drinking (Heavy Drinking Days Past 90 Days [HDD90]) markers were significantly higher in Gr.2 vs. Gr.1. BL ALT, AST, AST:ALT and K18M65 were considerably higher in Gr.2. Dysregulated gut dysfunction and elevated immune activity were evident in Gr.2 characterized by TNF-α, IL-8 and LPS levels. After SOC, Gr.2 showed improvement in AST, ALT, AST/ALT ratio; and in the K18M65, K18M30 and K18M65/M30 ratio vs. Gr.1. The true positivity of BL IL-8 response to predict the improvement in K18M65 to normal levels among Gr.2 patients against those who did not have improvement after 2 w SOC was very high (AUROC = 0.830, p = 0.042). (4) Conclusions: Gut dysfunction, elevated cytokine response and necrotic liver cell death were elevated in AUD patients with early-stage ALD. K18 showed promise as a predictive theragnostic factor to differentiate among the AUD patients with early-stage ALD and baseline fibrosis who had improvement in liver injury against those who did not, by the levels of baseline IL-8. 相似文献
23.
24.
25.
Sing Teang Kong Hai-Shu Lin Jianhong Ching Huiqing Xie Paul C. Ho 《International journal of molecular sciences》2022,23(13)
The immediate and delayed metabolic changes in rats treated with valproate (VPA), a drug used for the treatment of epilepsy, were profiled. An established approach using dried blood spots (DBS) as sample matrices for gas chromatography/mass spectrometry-based metabolomics profiling was modified using double solvents in the extraction of analytes. With the modified method, some of the previously undetectable metabolites were recovered and subtle differences in the metabolic changes upon exposure to a single dose of VPA between males and female rats were identified. In male rats, changes in 2-hydroxybutyric acid, pipecolic acid, tetratriacontane and stearic acid were found between the control and treatment groups at various time points from 2.5 h up to 24 h. In contrast, such differences were not observed in female rats, which could be caused by the vast inter-individual variations in metabolite levels within the female group. Based on the measured DBS drug concentrations, clearance and apparent volume of distribution of VPA were estimated and the values were found to be comparable to those estimated previously from full blood drug concentrations. The current study indicated that DBS is a powerful tool to monitor drug levels and metabolic changes in response to drug treatment. 相似文献
26.
27.
Jiang Ouyang Ling Zhang Leijiao Li Wei Chen Zhongmin Tang Xiaoyuan Ji Chan Feng Na Tao Na Kong Tianfeng Chen You-Nian Liu Wei Tao 《纳微快报(英文)》2021,(6):108-125
Stanene(Sn)-based materials have been extensively applied in industrial production and daily life,but their potential biomedi-cal application remains largely un... 相似文献
28.
介绍了智能网(IN)与In-ternet互通(PINT)的系统原理,以及PINT和SPIRITS等两类互通业务的网络结构,给出了智能网与Inter-net互通的模型。讨论了智能网与In-ternet互通的实现,并给出了一个PINT业务实例-点击拨号业务。 相似文献
29.
Renal inflammation is an initial pathological process during progressive renal injury regardless of the initial cause. Macrophage migration inhibitory factor (MIF) is a truly proinflammatory stress mediator that is highly expressed in a variety of both inflammatory cells and intrinsic kidney cells. MIF is released from the diseased kidney immediately upon stimulation to trigger renal inflammation by activating macrophages and T cells, and promoting the production of proinflammatory cytokines, chemokines, and stress molecules via signaling pathways involving the CD74/CD44 and chemokine receptors CXCR2, CXCR4, and CXCR7 signaling. In addition, MIF can function as a stress molecule to counter-regulate the immunosuppressive effect of glucocorticoid in renal inflammation. Given the critical position of MIF in the upstream inflammatory cascade, this review focuses on the regulatory role and molecular mechanisms of MIF in kidney diseases. The therapeutic potential of targeting MIF signaling to treat kidney diseases is also discussed. 相似文献
30.